Review



primary antibody cgas  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech primary antibody cgas
    Primary Antibody Cgas, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 202 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody cgas/product/Proteintech
    Average 96 stars, based on 202 article reviews
    primary antibody cgas - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    94
    MedChemExpress cgas activation
    Cgas Activation, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgas activation/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cgas activation - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    86
    Thermo Fisher gene exp mb21d1 mm01147496 m1
    Gene Exp Mb21d1 Mm01147496 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp mb21d1 mm01147496 m1/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    gene exp mb21d1 mm01147496 m1 - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress cgas sting signaling pathway agonists adu s100
    Cgas Sting Signaling Pathway Agonists Adu S100, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgas sting signaling pathway agonists adu s100/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    cgas sting signaling pathway agonists adu s100 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    96
    Proteintech primary antibody cgas
    Primary Antibody Cgas, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody cgas/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibody cgas - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti cgas
    Anti Cgas, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cgas/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti cgas - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    94
    InvivoGen cgas
    Cgas, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgas/product/InvivoGen
    Average 94 stars, based on 1 article reviews
    cgas - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    96
    Proteintech cgas
    Cgas, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgas/product/Proteintech
    Average 96 stars, based on 1 article reviews
    cgas - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    97
    InvivoGen cgas activator
    A) Scheme of treatment of <t>control</t> <t>myoblasts</t> with <t>cGAS</t> agonist during the myoblast differentiation process (n=3 independent treatments). B) Representative image of control myoblasts treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. C) Quantification of the fusion index of control treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. *p<0.01. D) Maturation index of control myoblasts treated with lipofectamine (mock) or agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. n.s. not significant. E) Quantification of cGAS agonist-treated myotube area. Means were tested using a one-way ANOVA test. ****p<0.00001. F) Quantification of cGAS agonist-treated myotube width. Means were tested using a one-way ANOVA test. **p<0.001. G) Quantification of cGAS agonist-treated myotube length. Means were tested using a one-way ANOVA test. *p<0.01. H) qPCR for IFNB expression in cGAS agonist-treated myotubes. Means were tested using a one-way ANOVA test. *p<0.01. I) ELISA measurement of IFNB secretion by cGAS agonist-treated and mock myotubes. Means were tested using a one-way ANOVA test. n.s. not significant.
    Cgas Activator, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cgas activator/product/InvivoGen
    Average 97 stars, based on 1 article reviews
    cgas activator - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    96
    Proteintech antibodies against cgas
    A) Scheme of treatment of <t>control</t> <t>myoblasts</t> with <t>cGAS</t> agonist during the myoblast differentiation process (n=3 independent treatments). B) Representative image of control myoblasts treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. C) Quantification of the fusion index of control treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. *p<0.01. D) Maturation index of control myoblasts treated with lipofectamine (mock) or agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. n.s. not significant. E) Quantification of cGAS agonist-treated myotube area. Means were tested using a one-way ANOVA test. ****p<0.00001. F) Quantification of cGAS agonist-treated myotube width. Means were tested using a one-way ANOVA test. **p<0.001. G) Quantification of cGAS agonist-treated myotube length. Means were tested using a one-way ANOVA test. *p<0.01. H) qPCR for IFNB expression in cGAS agonist-treated myotubes. Means were tested using a one-way ANOVA test. *p<0.01. I) ELISA measurement of IFNB secretion by cGAS agonist-treated and mock myotubes. Means were tested using a one-way ANOVA test. n.s. not significant.
    Antibodies Against Cgas, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against cgas/product/Proteintech
    Average 96 stars, based on 1 article reviews
    antibodies against cgas - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Proteintech anti cgas antibody
    A) Scheme of treatment of <t>control</t> <t>myoblasts</t> with <t>cGAS</t> agonist during the myoblast differentiation process (n=3 independent treatments). B) Representative image of control myoblasts treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. C) Quantification of the fusion index of control treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. *p<0.01. D) Maturation index of control myoblasts treated with lipofectamine (mock) or agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. n.s. not significant. E) Quantification of cGAS agonist-treated myotube area. Means were tested using a one-way ANOVA test. ****p<0.00001. F) Quantification of cGAS agonist-treated myotube width. Means were tested using a one-way ANOVA test. **p<0.001. G) Quantification of cGAS agonist-treated myotube length. Means were tested using a one-way ANOVA test. *p<0.01. H) qPCR for IFNB expression in cGAS agonist-treated myotubes. Means were tested using a one-way ANOVA test. *p<0.01. I) ELISA measurement of IFNB secretion by cGAS agonist-treated and mock myotubes. Means were tested using a one-way ANOVA test. n.s. not significant.
    Anti Cgas Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cgas antibody/product/Proteintech
    Average 96 stars, based on 1 article reviews
    anti cgas antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    A) Scheme of treatment of control myoblasts with cGAS agonist during the myoblast differentiation process (n=3 independent treatments). B) Representative image of control myoblasts treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. C) Quantification of the fusion index of control treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. *p<0.01. D) Maturation index of control myoblasts treated with lipofectamine (mock) or agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. n.s. not significant. E) Quantification of cGAS agonist-treated myotube area. Means were tested using a one-way ANOVA test. ****p<0.00001. F) Quantification of cGAS agonist-treated myotube width. Means were tested using a one-way ANOVA test. **p<0.001. G) Quantification of cGAS agonist-treated myotube length. Means were tested using a one-way ANOVA test. *p<0.01. H) qPCR for IFNB expression in cGAS agonist-treated myotubes. Means were tested using a one-way ANOVA test. *p<0.01. I) ELISA measurement of IFNB secretion by cGAS agonist-treated and mock myotubes. Means were tested using a one-way ANOVA test. n.s. not significant.

    Journal: bioRxiv

    Article Title: Genomic stress drives activation of interferon signaling and innate immune pathways during SMA Type II myoblasts differentiation

    doi: 10.64898/2025.12.23.696216

    Figure Lengend Snippet: A) Scheme of treatment of control myoblasts with cGAS agonist during the myoblast differentiation process (n=3 independent treatments). B) Representative image of control myoblasts treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. C) Quantification of the fusion index of control treated with lipofectamine (mock) or cGAS agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. *p<0.01. D) Maturation index of control myoblasts treated with lipofectamine (mock) or agonist after 3 days of differentiation. Means were tested using a one-way ANOVA test. n.s. not significant. E) Quantification of cGAS agonist-treated myotube area. Means were tested using a one-way ANOVA test. ****p<0.00001. F) Quantification of cGAS agonist-treated myotube width. Means were tested using a one-way ANOVA test. **p<0.001. G) Quantification of cGAS agonist-treated myotube length. Means were tested using a one-way ANOVA test. *p<0.01. H) qPCR for IFNB expression in cGAS agonist-treated myotubes. Means were tested using a one-way ANOVA test. *p<0.01. I) ELISA measurement of IFNB secretion by cGAS agonist-treated and mock myotubes. Means were tested using a one-way ANOVA test. n.s. not significant.

    Article Snippet: Myoblasts were transfected at 80% confluence with 1mg/mL cGAS activator (2’3’-cGAMP Invivogen #tlrl-nacga23-02) using Lipofectamine 2000 (Invitrogen) in differentiation media according to the manufacturer’s instructions.

    Techniques: Control, Expressing, Enzyme-linked Immunosorbent Assay